Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$10.97 - $26.84 $3.45 Million - $8.44 Million
-314,553 Reduced 19.53%
1,295,943 $33 Million
Q2 2023

Aug 14, 2023

SELL
$22.4 - $34.92 $8.01 Million - $12.5 Million
-357,679 Reduced 18.17%
1,610,496 $37 Million
Q1 2023

May 15, 2023

BUY
$24.84 - $38.75 $302,998 - $472,672
12,198 Added 0.62%
1,968,175 $58.3 Million
Q4 2022

Feb 14, 2023

SELL
$19.57 - $30.92 $793,602 - $1.25 Million
-40,552 Reduced 2.03%
1,955,977 $48.8 Million
Q3 2022

Nov 14, 2022

BUY
$20.91 - $34.27 $41.7 Million - $68.4 Million
1,996,529 New
1,996,529 $43.5 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $1.93B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.